Picture of GI Innovation logo

358570 GI Innovation Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapSucker Stock

Annual cashflow statement for GI Innovation, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-150,742-79,833-55,022-59,007-35,135
Depreciation
Amortisation
Non-Cash Items124,77817,4718,92714,998-2,867
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-2,761-3,3451,592-2,5192,710
Change in Accounts Receivable
Change in Other Assets
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-26,577-62,550-41,174-43,427-32,303
Capital Expenditures-4,922-2,970-579-24.7-7,536
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-134,24965,95422,84215,275-35,777
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-139,17162,98422,26315,250-43,313
Financing Cash Flow Items-62.5-801-140-1,670
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities161,492-32.125,10920,617114,293
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-4,2564026,198-7,56038,677